Leflunomide is an FDA approved drug for the treatment of RA and is an inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH) [22–24], which is the rate limiting enzyme in the de novo pyrimidine synthesis pathway. The gene discussed is DHODH; the disease is rheumatoid arthritis.